A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute and Roswell Park Comprehensive Cancer Center report in a new study published today by the New England Journal of Medicine.

One of the core focuses of Roswell Park Comprehensive Cancer Center’s Department of Cancer Prevention & Control is to assess the impact of cancer across Western New York (WNY). This team has compiled a new resource to report to the community those cancers that are most prevalent, documenting noteworthy changes in cancer incidence, deaths from cancer and variations in these trends among people of different races or ethnicities.

Recognizing our efforts globally on delivering high-quality cancer care to our patients, Newsweek has once again named Roswell Park Comprehensive Cancer Center to its list of World’s Best Specialized Hospitals for Oncology 2023. It is the only Buffalo-area center to be included on the full list of 300 top cancer centers internationally.